Madrigal Pharmaceuticals, Inc. MDGL Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s shares (diluted)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported shares (diluted) of 29M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s shares (diluted) increased by 3.4% year-over-year, from 28.1M to 29M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s shares (diluted) has grown at a 14.4% compound annual growth rate (CAGR), from 66.1M to 113.2M.
- What does shares (diluted) mean?
- The average number of shares that would exist if all potential sources of new shares were converted.
- How do you interpret shares (diluted)?
- A higher count relative to basic shares indicates a larger overhang of potential dilution from employee compensation or debt instruments.
- How does shares (diluted) compare across companies?
- Varies significantly based on the company's use of stock-based compensation and convertible debt financing.